Centessa Pharmaceuticals PLC 260-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 10/06/22 CEST
3.72UNCH (UNCH)
52 week range
3.30 - 13.60
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.30
  • 52 Week High13.60
  • 52 Week High Date10/04/21
  • 52 Week Low3.30
  • 52 Week Low Date06/09/22

Key Stats

  • Market Cap379.24M
  • Shares Out94.34M
  • 10 Day Average Volume2.27
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-62.23

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close8.30
  • 52 Week High13.60
  • 52 Week High Date10/04/21
  • 52 Week Low3.30
  • 52 Week Low Date06/09/22
  • Market Cap379.24M
  • Shares Out94.34M
  • 10 Day Average Volume2.27
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-62.23

RATIOS/PROFITABILITY

  • EPS (TTM)-2.29
  • P/E (TTM)-1.62
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Centessa Pharmaceuticals PLC

 

Profile

MORE
Centessa Pharmaceuticals plc (Centessa) is a pharmaceutical company. The Company's asset-centric programs range from discovery-stage to late-stage development and include diverse therapeutic areas such as oncology, hematology, immunology/inflammation, neuroscience, hepatology, pulmonology and nephrology. Its portfolio consists of approximately 16 conviction programs, including four programs evaluated in clinical trials and 12 additional preclinical programs. Centessa's...
Francesco de Rubertis Ph.D.
Independent Chairman of the Board
Saurabh Saha M.D., Ph.D.
Chief Executive Officer, Director
Gregory Weinhoff M.D.
Chief Financial Officer, Chief Accounting Officer
Thomas Templeman Ph.D.
Chief Technology Officer
Antoine Yver M.D.
Executive Vice President and Chairman of Development
Address
3Rd Floor, 1 Ashley Road
Altrincham
WA14 2DT
United Kingdom